Drug-Drug Interaction Study of Casdatifan in Healthy Adult Participants (ARC-29)

Completed · Phase 1

Conditions studied: Healthy Participants

In brief

The purpose of the study is to assess the effects of multiple doses of itraconazole (a strong CYP3A4 inhibitor) on single dose PK of casdatifan in healthy adults and to assess the effects of multiple doses of phenytoin (a strong CYP3A4 inducer) on single dose PK of casdatifan in healthy adults.

Key facts

Study ID
NCT06919991
Run by
Arcus Biosciences, Inc.
People needed
14
Starts
2025-05-02
Expected to finish
2025-10-18
Last updated by the study team
2025-11-13

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.